These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 33185955)

  • 1. Using protein microarray to identify and evaluate autoantibodies to tumor-associated antigens in ovarian cancer.
    Ma Y; Wang X; Qiu C; Qin J; Wang K; Sun G; Jiang D; Li J; Wang L; Shi J; Wang P; Ye H; Dai L; Jiang BH; Zhang J
    Cancer Sci; 2021 Feb; 112(2):537-549. PubMed ID: 33185955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer.
    Wang P; Qin J; Ye H; Li L; Wang X; Zhang J
    J Cell Biochem; 2019 Mar; 120(3):3091-3100. PubMed ID: 30484895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer.
    Cheng Y; Li Q; Sun G; Li T; Zou Y; Ye H; Wang K; Shi J; Wang P
    Sci Rep; 2024 Apr; 14(1):9757. PubMed ID: 38684875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays.
    Yang Q; Qin J; Sun G; Qiu C; Jiang D; Ye H; Wang X; Dai L; Zhu J; Wang P; Zhang J
    Clin Transl Gastroenterol; 2020 Dec; 12(1):e00284. PubMed ID: 33346593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor associated antigens or anti-TAA autoantibodies as biomarkers in the diagnosis of ovarian cancer: a systematic review with meta-analysis.
    Shi JX; Qin JJ; Ye H; Wang P; Wang KJ; Zhang JY
    Expert Rev Mol Diagn; 2015 Jun; 15(6):829-52. PubMed ID: 25959246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer.
    Qiu C; Duan Y; Wang B; Shi J; Wang P; Ye H; Dai L; Zhang J; Wang X
    Front Immunol; 2021; 12():698312. PubMed ID: 34489945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer.
    Liu W; Wang P; Li Z; Xu W; Dai L; Wang K; Zhang J
    Scand J Immunol; 2009 Jan; 69(1):57-63. PubMed ID: 19140877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer.
    Sun H; Shi JX; Zhang HF; Xing MT; Li P; Dai LP; Luo CL; Wang X; Wang P; Ye H; Li LX; Zhang JY
    Tumour Biol; 2017 Jun; 39(6):1010428317699132. PubMed ID: 28618923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Autoantibodies against LRDD, STC1, and FOXA1 as Biomarkers in the Detection of Ovarian Cancer.
    Duan Y; Cui C; Qiu C; Sun G; Wang X; Wang P; Ye H; Dai L; Shi J
    Dis Markers; 2022; 2022():6657820. PubMed ID: 35273656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis.
    Villar-Vázquez R; Padilla G; Fernández-Aceñero MJ; Suárez A; Fuente E; Pastor C; Calero M; Barderas R; Casal JI
    Proteomics; 2016 Apr; 16(8):1280-90. PubMed ID: 26915739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.
    Zhou SL; Ku JW; Fan ZM; Yue WB; Du F; Zhou YF; Liu YL; Li Y; Tang S; Hu YL; Hu XP; Hou ZC; Liu J; Liu Y; Feng XS; Wang LD
    Dis Esophagus; 2015; 28(4):371-9. PubMed ID: 24612004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using recursive partitioning approach to select tumor-associated antigens in immunodiagnosis of gastric adenocarcinoma.
    Qin J; Wang S; Shi J; Ma Y; Wang K; Ye H; Zhang X; Wang P; Wang X; Song C; Dai L; Wang K; Jiang B; Zhang J
    Cancer Sci; 2019 Jun; 110(6):1829-1841. PubMed ID: 30950146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer.
    Li J; Wang LJ; Ying X; Han SX; Bai E; Zhang Y; Zhu Q
    Scand J Immunol; 2012 Mar; 75(3):342-9. PubMed ID: 22010875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a panel of tumor-associated antigens in breast cancer.
    Pagaza-Straffon C; Marchat LA; Herrera L; Díaz-Chávez J; Avante MG; Rodríguez YP; Arreola MC; López-Camarillo C
    Cancer Biomark; 2020; 27(2):207-211. PubMed ID: 31839604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of paraneoplastic antigens reveals TRIM21 autoantibodies as biomarker for early detection of ovarian cancer in combination with autoantibodies to NY-ESO-1 and TP53.
    Hurley LC; Levin NK; Chatterjee M; Coles J; Muszkat S; Howarth Z; Dyson G; Tainsky MA
    Cancer Biomark; 2020; 27(3):407-421. PubMed ID: 32083570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer.
    Qin JJ; Wang XR; Wang P; Ren PF; Shi JX; Zhang HF; Xia JF; Wang KJ; Song CH; Dai LP; Zhang JY
    Asian Pac J Cancer Prev; 2014; 15(6):2635-40. PubMed ID: 24761876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
    Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
    Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Serological Proteome Analysis to Identify Serum Anti-Nucleophosmin 1 Autoantibody as a Potential Biomarker in European-American and African-American Patients With Prostate Cancer.
    Dai L; Li J; Xing M; Sanchez TW; Casiano CA; Zhang JY
    Prostate; 2016 Nov; 76(15):1375-86. PubMed ID: 27418398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.
    Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY
    Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens.
    Dai L; Li J; Ortega R; Qian W; Casiano CA; Zhang JY
    J Immunol Res; 2014; 2014():827827. PubMed ID: 24860838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.